سعر جيليفين 1.2 مل (300 ميكروجرام) 5 امبول 2026

Filgrastim (recombinant G-CSF) 300 mcg in 1.2 ml injection, pack of 5 ampoules, listed by Egyptian directories as a tender & export pack (Vacsera > International Trading Office).

• Decrease the incidence of infection (febrile neutropenia) in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs.Population: Adults and childrenDailyMed (U.S. National Library of Medicine)
• Reduce time to neutrophil recovery and duration of fever after induction or consolidation chemotherapy for acute myeloid leukaemia.Population: AdultsDailyMed (U.S. National Library of Medicine)
• Mobilisation of autologous haematopoietic progenitor cells into peripheral blood for leukapheresis; reduce neutropenia after myeloablative chemotherapy with bone marrow transplantation; severe chronic neutropenia.Population: Adults and childrenDailyMed (U.S. National Library of Medicine)

• Most common in nonmyeloid malignancies on myelosuppressive chemotherapy (>=5% over placebo): pyrexia, pain, rash, cough and dyspnoea; in AML: pain, epistaxis and rash.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• History of serious allergic reactions to human granulocyte colony-stimulating factors such as filgrastim or pegfilgrastim.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Splenic rupture (sometimes fatal): evaluate left upper abdominal or shoulder pain. ARDS: discontinue if it develops. Serious allergic reactions including anaphylaxis: permanently discontinue. Fatal sickle cell crises in sickle cell disorders. Glomerulonephritis, alveolar haemorrhage, capillary leak syndrome, MDS/AML in breast and lung cancer patients, thrombocytopenia, leukocytosis, cutaneous vasculitis and aortitis have been reported.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Published observational data have not established an association between filgrastim use in pregnancy and major birth defects, miscarriage or adverse maternal or fetal outcomes; transplacental passage has been described.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Filgrastim transfers into human milk; case reports describe no adverse effects in breastfed infants; filgrastim products are not absorbed orally by neonates.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Filgrastim: Binds G-CSF receptors on haematopoietic cells, stimulating proliferation, differentiation commitment and some end-cell functions, mainly of neutrophils.